| Date | Research Question / Title | Unique ID | Research Team |
|---|---|---|---|
| April 21, 2021 | What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? | EOC210302 RR | EOC |
| October 7, 2021 | What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? | EOC210902 RR | EOC |
| January 12, 2022 | In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease? | EOC211201 RR | EOC |
| March 10, 2022 | What is the safety/efficacy of the Novavax COVID-19 vaccine? | EOC220302 RR | EOC |
| June 6, 2022 | What is known about hybrid immunity to COVID-19? | INF220501 RR | Infectious Disease |
